代谢学：市场动向

Abstract

This market insight report gives an insight into Metabolomics Technologies - Combined/Integrated Systems, Hardware Systems for metabolic analytics and Software Systems. Estimates and projections for the total global Metabolomics Technologies' market are given by geographic regions encompassing United States, Canada, Europe, Asia-Pacific, and Japan . Business profiles of 26 major companies are discussed in the report. The report covers 221 companies that are engaged in Metabolomics research and supply of products and/or services. Major Contract Research Organizations and Universities serving Metabolomics market are also covered in the Corporate Directory section of this report. Information related to recent product releases, product developments, partnerships, collaborations, and mergers and acquisitions is also covered in the report. A total of 91 exhibits complement the text.

Table of Contents

I. SCOPE AND METHODOLOGY

II. REPORT SYNOPSIS

• 1. Introduction
  • Segmentation of Metabolomics Technologies
• 2. Global Market Analysis
  • Exhibit 1: Metabolomics (2005-2012) - Global Market Analysis (Current & Future) in US$ Million (Graphical Representation included)
  • Analysis by Metabolomics Technologies
  • Combined Systems - The Fastest Growing Technology
  • Market Analysis
    • Exhibit 2: Combined Systems of Metabolomics (2005-2012) - Global Market Analysis (Current & Future) by Geographic Region for United States, Europe, Japan, Asia-Pacific, Canada and Rest of World in US$ Million (Graphical Representation included)
    • Exhibit 3: Combined Systems of Metabolomics (2006, 2009 and 2012) - Percentage Breakdown of Global Market Value by Geographic Region for United States, Europe, Japan, Asia-Pacific, Canada and Rest of World (Graphical Representation included)
  • Hardware Systems - The Fading-out Technology
    • Exhibit 4: Hardware Systems of Metabolomics (2005-2012) - Global Market Analysis (Current & Future) by Geographic Region for United States, Europe, Japan, Asia-Pacific, Canada and Rest of World in US$ Million (Graphical Representation included)
    • Exhibit 5: Hardware Systems of Metabolomics (2006, 2009 and 2012) - Percentage Breakdown of Global Market Value by Geographic Region for United States, Europe, Japan, Asia-Pacific, Canada and Rest of World
  • Software Systems - Ever Growing in Emerging Markets
  • Market Analysis
    • Exhibit 6: Software Systems of Metabolomics (2005-2012) - Global Market Analysis (Current & Future) by Geographic Region for United States, Europe, Japan, Asia-Pacific, Canada and Rest of World in US$ Million (Graphical Representation included)
    • Exhibit 7: Software Systems of Metabolomics (2006, 2009 and 2012) - Percentage Breakdown of Global Market Value by Geographic Region for United States, Europe, Japan, Asia-Pacific, Canada and Rest of World
    • Exhibit 8: List of Major Global Companies
• 3. Regional Market Analysis
  • North America
    • Exhibit 9: Metabolomics (2005-2012) - North American Market Analysis (Current & Future) in US$ Million (Graphical Representation included)
  • Major Companies in North America
    • Acadia Pharmaceuticals, Inc. (USA)
    • Accelrys, Inc. (USA)
    • Agilent Technologies, Inc. (USA)
    • Amphora Discovery Corporation (USA)
    • Applied Biosystems Group (USA)
    • BG Medicine, Inc. (USA)
    • Bio-Rad Laboratories, Inc. (USA)
    • Bruker Biosciences Corporation (USA)
    • Bruker Daltonics, Inc. (USA)
    • Caliper Life Sciences, Inc. (USA)
    • Chenomx, Inc. (Canada)
    • Cogenics (USA)
    • Genego, Inc. (USA)
    • Infometrix, Inc. (USA)
    • MDS Sciex (Canada)
    • Metabolon, Inc. (USA)
    • Pharmaceutical Product Development, Inc. (USA)
    • Phenomenome Discoveries, Inc. (Canada)
    • SiDMAP (USA)
    • Thermo Fisher Scientific, Inc. (USA)
    • Waters Corporation (USA)
  • Analysis by Metabolomics Technologies
    • Combined Systems
      • Exhibit 10: Combined Systems of Metabolomics (2005-2012) - North American Market Analysis (Current & Future) by Geographic Region for United States and Canada in US$ Million (Graphical Representation included)
      • Exhibit 11: Combined Systems of Metabolomics (2006, 2009 and 2012) - Percentage Breakdown of North American Market Value by Geographic Region for United States and Canada (Graphical Representation included)
    • Hardware Systems
      • Exhibit 12: Hardware Systems of Metabolomics (2005-2012) - North American Market Analysis (Current & Future) by Geographic Region for United States and Canada in US$ Million (Graphical Representation included)
      • Exhibit 13: Hardware Systems of Metabolomics (2006, 2009 and 2012) - Percentage Breakdown of North American Market Value by Geographic Region for United States and Canada (Graphical Representation included)
    • Software Systems
      • Exhibit 14: Software Systems of Metabolomics (2005-2012) - North American Market Analysis (Current & Future) by Geographic Region for United States and Canada in US$ Million (Graphical Representation included)
      • Exhibit 15: Software Systems of Metabolomics (2006, 2009 and 2012) - Percentage Breakdown of North American Market Value by Geographic Region for United States and Canada (Graphical Representation included)
  • Europe
    • Exhibit 16: Metabolomics (2005-2012) - European Market Analysis (Current & Future) in US$ Million (Graphical Representation included)
    • Major Companies in Europe
    • Avogadro (France)
    • Biocrates Life Sciences AG (Austria)
    • Genedata AG (Switzerland)
    • Metabometrix Ltd. (UK)
    • Metanomics GmbH (Germany)
    • Analysis by Metabolomics Technologies
    • Combined Systems
      • Exhibit 17: Combined Systems of Metabolomics (2005-2012) - European Market Analysis (Current & Future) by Geographic Region for Germany, United Kingdom, Italy, Belgium, France, Spain, Switzerland, Sweden and Rest of Europe in US$ Million (Graphical Representation included)
      • Exhibit 18: Combined Systems of Metabolomics (2006, 2009 and 2012) - Percentage Breakdown of European Market Value by Geographic Region for Germany, United Kingdom, Italy, Belgium, France, Spain, Switzerland, Sweden and Rest of Europe (Graphical Representation included)
    • Hardware Systems
      • Exhibit 19: Hardware Systems of Metabolomics (2005-2012) - European Market Analysis (Current & Future) by Geographic Region for Germany, United Kingdom, Italy, Belgium, France, Spain, Switzerland, Sweden and Rest of Europe in US$ Million (Graphical Representation included)
      • Exhibit 20: Hardware Systems of Metabolomics (2006, 2009 and 2012) - Percentage Breakdown of European Market Value by Geographic Region for Germany, United Kingdom, Italy, Belgium, France, Spain, Switzerland, Sweden and Rest of Europe (Graphical Representation included)
    • Software Systems
      • Exhibit 21: Software Systems of Metabolomics (2005-2012) - European Market Analysis (Current & Future) by Geographic Region for Germany, United Kingdom, Italy, Belgium, France, Spain, Switzerland, Sweden and Rest of Europe in US$ Million (Graphical Representation included)
      • Exhibit 22: Software Systems of Metabolomics (2006, 2009 and 2012) - Percentage Breakdown of European Market Value by Geographic Region for Germany, United Kingdom, Italy, Belgium, France, Spain, Switzerland, Sweden and Rest of Europe (Graphical Representation included)
  • Asia-Pacific
    • Exhibit 23: Metabolomics (2005-2012) - Asia-Pacific Market Analysis (Current & Future) in US$ Million (Graphical Representation included)
    • Analysis by Metabolomics Technologies
    • Combined Systems
      • Exhibit 24: Combined Systems of Metabolomics (2005-2012) - Asia-Pacific Market Analysis (Current & Future) by Geographic Region for China, India, Australia and Rest of Asia-Pacific in US$ Million (Graphical Representation included)
      • Exhibit 25: Combined Systems of Metabolomics (2006, 2009 and 2012) - Percentage Breakdown of Asia-Pacific Market Value by Geographic Region for China, India, Australia and Rest of Asia-Pacific (Graphical Representation included)
    • Hardware Systems
      • Exhibit 26: Hardware Systems of Metabolomics (2005-2012) - Asia-Pacific Market Analysis (Current & Future) by Geographic Region for China, India, Australia and Rest of Asia-Pacific in US$ Million (Graphical Representation included)
      • Exhibit 27: Hardware Systems of Metabolomics (2006, 2009 and 2012) - Percentage Breakdown of Asia-Pacific Market Value by Geographic Region for China, India, Australia and Rest of Asia-Pacific (Graphical Representation included)
    • Software Systems
      • Exhibit 28: Software Systems of Metabolomics (2005-2012) - Asia-Pacific Market Analysis (Current & Future) by Geographic Region for China, India, Australia and Rest of Asia-Pacific in US$ Million (Graphical Representation included)
      • Exhibit 29: Software Systems of Metabolomics (2006, 2009 and 2012) - Percentage Breakdown of Asia-Pacific Market Value by Geographic Region for China, India, Australia and Rest of Asia-Pacific (Graphical Representation included)
  • Rest of World
    • Exhibit 30: Metabolomics (2005-2012) - Rest of World Market Analysis (Current & Future) in US$ Million (Graphical Representation included)

III. PRODUCT/TECHNOLOGY RESEARCH

• 1. Introduction
  • Backdrop
  • Metabolomics - The Definition
  • History of Metabolomics
    • Metabolomic Profiling
      • Separation Methods
      • Detection Methods
    • Metabolomics Growth Trends - Global Markets
      • Exhibit 31: Global Market for Metabolomics: Geographic Regions (Asia-Pacific, Canada, Europe, Japan and United States) Ranked by Projected CAGR for 2005 through 2012 (Graphical Representation included)
  • Metabolomic Profiling - The Applications
    • Toxicity Assessment/Toxicology
    • Functional Genomics
    • The Human Metabolome Project
    • Human Metabolome Database
  • Systems Biology Or Integrative Biology
    • Biomolecular Networks
    • HiRes
  • Computer Simulation of Metabolism
    • Computer Simulation and the Design of Drugs
  • Metabolic Activity Preservation in Lyophilized Human Erythrocytes
  • Metabolic flux Ratio Study on Escherichia coli Mutants Using GC-MS Method
  • Metabolic profiling
  • Metabolomic Profiling - The Technologies
    • The LC-MS Technique
    • Liquid Chromatographic Radioactivity Detection Techniques
    • Structural Genomics in Combination with Metabolic Profiling
    • Techniques for Redox Metabolic Profiling
  • Metabolomics and Metabonomics
    • Metabolism: Metabolites and Metabolome
      • Metabolites
      • Metabolome
    • Human Nutrition Metabolome
    • Metabolomics and Human Health
      • Metabolomic Techniques for Genetic Mapping
    • Human Metabolic Diagnosis
  • Metabolomics in Human Nutrition - Prospects and Experiments
    • The Human Nutrition Metabolome Generation
      • Pattern-Recognition Methods and Human Nutrition
      • Nutrition Evaluation with Pharmacology and Toxicology
  • How Metabolites Affect Food
  • Metabolomics - Related with other Omics?
    • Proteomics, Genomics and Metabolomics
    • Functional Genomics
      • The Shortcomings/Delays in Functional Genomics Strategies
    • Proteomics
    • Lipidomics
      • The Definition
      • The Concept of Lipidomics
      • Traditional Analysis of Lipids
      • Lipidomics Aids Treatment of CNS Related Diseases
    • Glycomics
      • Study of Glycobiology - Analytical High-Throughput Technologies
    • Transcriptomics
      • Arabidopsis Thaliana
      • Signal Transduction Process
      • Dietary Leucine Excess
  • Analysis of Metabolic Pathways
    • Types of Metabolic Pathways Databases
      • MMCD
      • BRENDA
      • EMP
      • Enzyme Nomenclature Database
      • IntEnz
      • Kinase Pathway Database
      • PhosphaBase
      • PRECISE
      • TECRDB
      • BOCD
      • EcoCyc
      • KEGG Metabolic Pathways
    • Boehringer Mannheim - Biochemical Pathways
  • Environmental Metabolomics
    • Components for the Study of Metabolomics
    • Challenges to Environmental Metabolomics
  • Advantages of Metabolomics
    • Other Side of the Coin
  • Metabolomics to Probe GM foods
• 2. Metabolomics Technologies
  • Sophisticated Analytical Tools Required in Metabolomics
  • Scope for Growth in NMR-based Analysis
  • The Bottom-up Approach
  • Blood as a Central Focus Theme
  • An Individualized Approach to Metabolomics
  • Growth Trends - Global Biomarker Discovery Technologies
    • Exhibit 32: Global Market for Metabolomics: Metabolomics Technologies (Combined Systems, Hardware Systems and Software Systems ) Ranked by Projected CAGR for 2005 through 2012 (Graphical Representation included)
  • Categorization of Metabolomics Technologies
    • Mass Spectrometry
      • Applications of Mass Spectrometers
        • Protein Detection and Analysis
        • Protein Quantitation
    • Growth Trend for Combined Systems
      • Exhibit 33: Global Market for Combined Systems for Metabolomics: Geographic Regions (Canada, Europe, Asia-Pacific, Japan and United States) Ranked by Projected CAGR for 2005 through 2012 (Graphical Representation included)
    • Protein Structure Probing
    • Space Exploration
    • Respiratory Gas Monitoring
    • Isotope Ratio Evaluation
    • Exposure and Burial Dating
    • Growth Trend for Software Systems
      • Exhibit 34: Global Market for Software Systems for Metabolomics: Geographic Regions (Asia-Pacific, Europe, Canada, Japan and United States) Ranked by Projected CAGR for 2005 through 2012 (Graphical Representation included)
    • Trace Gas Analysis
    • Pharmacokinetics
    • Metabolites Identification and Biomarkers Development
  • Nuclear Magnetic Resonance
    • Fourier Spectroscopy
      • Multi-Dimensional - A Type of FT-NMR
    • NMR Based Metabolomics
    • Applications of NMR
  • Liquid Chromatography/Gas Chromatography
  • High Performance Liquid Chromatography
  • Lab-on-a-Chip
  • Capillary Electrophoresis
  • Electrochemical Array
    • Application of Electrochemical Array Detection in Metabolomics
  • Fourier-Transform Infrared Spectroscopy
    • Qualitative Analysis with FT - IR7
  • Challenges for Metabolomics
• 3. Metabolomics - A Pharma and Healthcare Perspective
  • Metabolomics - Significance of Individual Health
    • Need for Awareness of Balanced Diet
      • Creation of Basic Structure
        • The Creation Stage
          • Development of Technologies
          • Database Collection on Personalized Metabolites Health
        • The Innovation Stage
          • Metabolism' s Role in Physical Condition
          • Pathways Ideal for Classifying Targets and Techniques
        • The Execution Stage
          • Execution of Personalized Evaluation Technologies
  • Clinical Chemistry and Metabolomics
  • Metabolomics in Biomarker Identification
    • Metabolite Biomarkers
      • Study of Biomarker Metabolites in Oryza Sativa (Rice)
      • Limitations of Metabolite Biomarkers
  • Personalized Medicine with Metabolomics
    • Pharmaco-Metabonomics
  • Application of Metabolomics in Transplantation
    • Exhibit 35: Reported Frequencies of Organ Transplantations (2006): Percentage Breakdown of Frequencies for Kidney, Liver, Heart, Pancreas and Lung Transplantations (Graphical Representation included)
    • The Role of Metabolomics in Transplantation of Various Organs
      • Kidney Transplantation
      • Liver Transplantation
      • Heart Transplantation
  • Metabolomics - In the Process of Drug Discovery
    • Metabolomics to Save Time and Cost in Initial Stages
    • Distinguishing Varieties of Animal Phenotypes
    • Biomarker Detection
      • Metabolic Profiling Approach for Biomarker Discovery
        • ESI-LC/MS Use in Identifying Biomarkers in Plant Extracts
        • Metabolic Profiles and Biomarkers Determine Toxic Drug Effects

IV. MARKET DYNAMICS

• 1. Market Overview
  • Global Market Analysis
    • Exhibit 36: Metabolomics (2005-2012) - Global Market Analysis (Current & Future) by Geographic Region for United States, Europe, Japan, Asia-Pacific, Canada and Rest of World in US$ Million (Graphical Representation included)
    • Exhibit 37: Metabolomics (2006, 2009 and 2012) - Percentage Breakdown of Global Market Value by Geographic Region for United States, Europe, Japan, Asia-Pacific, Canada and Rest of World (Graphical Representation included)
• 2. Major Companies in Metabolomics Industry
  • Acadia Pharmaceuticals, Inc. (USA)
  • Accelrys, Inc. (USA)
  • Agilent Technologies, Inc. (USA)
  • Amphora Discovery Corporation (USA)
  • Applied Biosystems Group (USA)
  • Avogadro (France)
  • BG Medicine, Inc. (USA)
  • Biocrates Life Sciences AG (Austria)
  • Bio-Rad Laboratories, Inc. (USA)
  • Bruker Biosciences Corporation (USA)
  • Caliper Life Sciences, Inc. (USA)
  • Chenomx, Inc. (Canada)
  • Cogenics (USA)
  • Genedata AG (Switzerland)
  • Genego, Inc. (USA)
  • Human Metabolome Technologies, Inc. (Japan)
  • MDS Sciex (Canada)
  • Metabolon, Inc. (USA)
  • Metabometrix Ltd. (UK)
  • Metanomics GmbH (Germany)
  • Pharmaceutical Product Development, Inc. (USA)
  • Phenomenome Discoveries, Inc. (Canada)
  • Shimadzu Corporation (Japan)
  • SiDMAP (USA)
  • Thermo Fisher Scientific, Inc. (USA)
  • Waters Corporation (USA)
• 3. Major Activities in Metabolomics Industry
  • UCB Collaborates with BioSeek for Evaluation of Compounds with BioMAP Systems
  • Bruker BioSciences to Acquire Privately Held Bruker BioSpin' s Companies
  • Agreement Gives U.S Food and Drug Administration an Access to Genedata Expressionist Platform
  • GeneGo Grants License for Usage of MetaCore to Oregon Health and Science University (OHSU)' s Facility
  • Metabolon Collaborates with US Army Medical Research Institute of Infectious Diseases
  • Metabolon Acquires Cogenics Icoria' s Patented Metabolomics and Toxicity Technologies
  • Bionas Enters into a Service Contract with Solvay Pharmaceuticals
  • GeneGo Licenses MetaCore to Biogen Idec
  • Chenomx Partners with GeneGo to Provide Metabolomics Data Integration
  • ** HMT Explains the Cause of Heterogeneity in Bacillus Subtilis Populations
  • Chenomx Inc. Awarded two Patents for NMR-based Mixture Analysis Computations
  • Nanosys and Bruker Daltonics Collaborate for Research, Development and Distribution of NALDI(TM)-TOF
  • MDS Acquires Entire Stake in MDC
  • Agilent Technologies Collaborates with Lipomics for Developing Research and Diagnostic Biomarker Assays
  • BG Medicine and Applied Biosystems Collaborate for Improving Biomarker Discovery and Development
  • AstraZeneca Employs ToxWiz to Determine the Effects of Liver Treatment Drugs
  • Nycomed Acquires ALTANA Pharma AG
  • Bayer AG Takes Over Schering AG
  • GeneData Collaborates with Serono for Intensifying Analysis on Screening
  • GenoLogics' Proteus™ to be Utilized by University of Leuven
  • GenoLogics' Geneus Solution to be Utilized for Genomics Research
  • Clinical Data Signs Pact with QTC
  • Ariadne Grants Pathway Studio License to NCI
  • GeneData Enters into Collaboration with Altanta and Introduces Hit Profiler
  • Agilent Signs Agreement with Mass Consortium
  • Bruker BioSciences Acquires Stake in Bruker Optics
  • GeneData Signs Partnership Agreement with INCA
  • Shimadzu Signs Partnership Agreement with Phenomenome
  • PathwayStudio® 4.0 of Ariadne Links up with Affymetrix GeneChip-compatible Applications Program
  • Cerep Signs Licensing Agreement with AstraZeneca
  • Chenomx Joins Hands with Umetrics to Offer Metabolomics Solutions
  • Biocrates signs Alliance Agreement with Altana...
  • Bio-Rad Enters into Partnership with Infometrix
  • NCTR Establishes Metabolomics Research Center
  • Syngenta Acquires Licenses from InforSense
  • Clinical Data Initiates Metabolomics Research of Lung Cancer Samples
  • CST Extends Agreement with AstraZeneca
  • Allied Biosystems Signs Alliance Agreement with MDS and Biocrates
  • PrecisionMed Enters into Collaboration with Phenomenome
  • PPD Takes Over SurroMed
• 4. Major Product Innovations/Launches in Metabolomics Industry
  • Chenomx, Inc. Launches the Upgraded Version of Metabolomics Software Solution
  • Metabolon to Provide mVision™ Service for Biomarker Discovery
  • Chenomx Inc. Introduces Metabolic Profiling Services
  • Applied Biosystems Launches StepOne™ Real-Time PCR System
  • Applied Biosystems Introduces TaqMan®
  • Discovery of APG16L1 as a New Gene Related to Crohn' s Disease
  • InnoMed Introduces a New Website for Data Transmission
  • GenoLogics Discovers Sophisticated Data Management Solutions for Various Applications
  • Phoenix Launches SureSpray Technology
  • Bio-Rad Releases Version 7.5 of its KnowItAll Informatics System
  • GenoLogics Introduces Geneus™
  • Ariadne Introduces Additional Pathway Database for PathwayStudio® and PathwayExpert™ Software
  • Thermo Electron (now Thermo Fisher Scientific) Launches Galileo LIMS v 3.2
  • Agilent Launches Liquid Chromatography Column
  • Ariadne Introduces New Software for Pathway Analysis
  • GeneData Launches Expressionist® Pro 3.0
  • Applied Biosystems and MDS Unveil MIDAS™ TRAQ Systems
  • Allied Biosystems and MDS Introduce Tempo™, a Liquid Chromatography System
  • GenoLogics Develops OmixLIMS
  • GeneGo Incorporates Accord Technology in MetaDrug™
  • Applied Biosystems and MDS Sciex Unveil MarkerView™ Software
  • Phenomenome Develops Solution for Colorectal Cancer Screening
  • Bio-Rad Laboratories Introduces ADMET Databases
  • Thermo Electron (now Thermo Fisher Scientific) Introduces LeadStream ADME/Tox Solution™
• 5. Regional Market Analysis
  • A. The United States
    • Market Analysis
      • Exhibit 38: Metabolomics (2005-2012) - United States Market Analysis (Current & Future) in US$ Million (Graphical Representation included)
      • Exhibit 39: List of Major Companies in the United States
    • Analysis by Metabolomics Technology
      • Exhibit 40: Metabolomics (2005-2012) - United States Market Analysis (Current & Future) by Metabolomic Technologies for Combined Systems, Hardware Systems and Software Systems in US$ Million (Graphical Representation included)
      • Exhibit 41: Metabolomics (2006, 2009 and 2012) - Percentage Breakdown of United States Market Value by Metabolomic Technologies for Combined Systems, Hardware Systems and Software Systems
  • B. Europe
    • Market Analysis
      • Exhibit 42: Metabolomics (2005-2012) - European Market Analysis (Current & Future) in US$ Million (Graphical Representation included)
      • Exhibit 43: List of Major Companies in Europe
    • Analysis by Geographic Region
      • Exhibit 44: Metabolomics (2005-2012) - European Market Analysis (Current & Future) by Geographic Region for Germany, United Kingdom, Italy, Belgium, France, Spain, Switzerland, Sweden and Rest of Europe in US$ Million (Graphical Representation included)
      • Exhibit 45: Metabolomics (2006, 2009 and 2012) - Percentage Breakdown of European Market Value by Geographic Region for Germany, United Kingdom, Italy, Belgium, France, Spain, Switzerland, Sweden and
    • Rest of Europe (Graphical Representation included)
    • Analysis by Metabolomics Technology
      • Exhibit 46: Metabolomics (2005-2012) - European Market Analysis (Current & Future) by Metabolomic Technologies for Combined Systems, Hardware Systems and Software Systems in US$ Million (Graphical Representation included)
      • Exhibit 47: Metabolomics (2006, 2009 and 2012) - Percentage Breakdown of European Market Value by Metabolomic Technologies for Combined Systems, Hardware Systems and Software Systems in US$ Million
  • European Metabolomics Market by Country
  • B1. Germany
    • German Market Analysis
    • Analysis by Metabolomics Technology
      • Exhibit 48: Metabolomics (2005-2012) - German Market Analysis (Current & Future) by Metabolomic Technologies for Combined Systems, Hardware Systems and Software Systems in US$ Million (Graphical Representation included)
      • Exhibit 49: Metabolomics (2006, 2009 and 2012) - Percentage Breakdown of German Market Value by Metabolomic Technologies for Combined Systems, Hardware Systems and Software Systems in US$ Million
  • B2. The United Kingdom
    • UK Market Analysis
    • Analysis by Metabolomics Technology
      • Exhibit 50: Metabolomics (2005-2012) - United Kingdom Market Analysis (Current & Future) by Metabolomic Technologies for Combined Systems, Hardware Systems and Software Systems in US$ Million (Graphical Representation included)
      • Exhibit 51: Metabolomics (2006, 2009 and 2012) - Percentage Breakdown of United Kingdom Market Value by Metabolomic Technologies for Combined Systems, Hardware Systems and Software Systems in US$ Million
  • B3. Italy
    • Italian Market Analysis
    • Analysis by Metabolomics Technology
      • Exhibit 52: Metabolomics (2005-2012) - Italian Market Analysis (Current & Future) by Metabolomic Technologies for Combined Systems, Hardware Systems and Software Systems in US$ Million (Graphical Representation included)
      • Exhibit 53: Metabolomics (2006, 2009 and 2012) - Percentage Breakdown of Italian Market Value by Metabolomic Technologies for Combined Systems, Hardware Systems and Software Systems in US$ Million
  • B4. Belgium
    • Belgian Market Analysis
    • Analysis by Metabolomics Technology
      • Exhibit 54: Metabolomics (2005-2012) - Belgian Market Analysis (Current & Future) by Metabolomic Technologies for Combined Systems, Hardware Systems and Software Systems in US$ Million (Graphical Representation included)
      • Exhibit 55: Metabolomics (2006, 2009 and 2012) - Percentage Breakdown of Belgian Market Value by Metabolomic Technologies for Combined Systems, Hardware Systems and Software Systems in US$ Million
  • B5. France
    • French Market Analysis
    • Analysis by Metabolomics Technology
      • Exhibit 56: Metabolomics (2005-2012) - French Market Analysis (Current & Future) by Metabolomic Technologies for Combined Systems, Hardware Systems and Software Systems in US$ Million (Graphical Representation included)
      • Exhibit 57: Metabolomics (2006, 2009 and 2012) - Percentage Breakdown of French Market Value by Metabolomic Technologies for Combined Systems, Hardware Systems and Software Systems in US$ Million
  • B6. Spain
    • Spanish Market Analysis
    • Analysis by Metabolomics Technology
      • Exhibit 58: Metabolomics (2005-2012) - Spanish Market Analysis (Current & Future) by Metabolomic Technologies for Combined Systems, Hardware Systems and Software Systems in US$ Million (Graphical Representation included)
      • Exhibit 59: Metabolomics (2006, 2009 and 2012) - Percentage Breakdown of Spanish Market Value by Metabolomic Technologies for Combined Systems, Hardware Systems and Software Systems in US$ Million
  • B7. Switzerland
    • Swiss Market Analysis
    • Analysis by Metabolomics Technology
      • Exhibit 60: Metabolomics (2005-2012) - Swiss Market Analysis (Current & Future) by Metabolomic Technologies for Combined Systems, Hardware Systems and Software Systems in US$ Million (Graphical Representation included)
      • Exhibit 61: Metabolomics (2006, 2009 and 2012) - Percentage Breakdown of Swiss Market Value by Metabolomic Technologies for Combined Systems, Hardware Systems and Software Systems in US$ Million
  • B8. Sweden
    • Swedish Market Analysis
    • Analysis by Metabolomics Technology
      • Exhibit 62: Metabolomics (2005-2012) - Swedish Market Analysis (Current & Future) by Metabolomic Technologies for Combined Systems, Hardware Systems and Software Systems in US$ Million (Graphical Representation included)
      • Exhibit 63: Metabolomics (2006, 2009 and 2012) - Percentage Breakdown of Swedish Market Value by Metabolomic Technologies for Combined Systems, Hardware Systems and Software Systems in US$ Million
  • B9. Rest of Europe
    • Rest of Europe Market Analysis
    • Analysis by Metabolomics Technology
      • Exhibit 64 Metabolomics (2005-2012) - Rest of Europe Market Analysis (Current & Future) by Metabolomic Technologies for Combined Systems, Hardware Systems and Software Systems in US$ Million (Graphical Representation included)
      • Exhibit 65: Metabolomics (2006, 2009 and 2012) - Percentage Breakdown of Rest of Europe Market Value by Metabolomic Technologies for Combined Systems, Hardware Systems and Software Systems in US$ Million
  • C. Japan
    • Market Analysis
      • Exhibit 66: Metabolomics (2005-2012) - Japanese Market Analysis (Current & Future) in US$ Million (Graphical Representation included)
      • Exhibit 67: List of Major Companies in Japan
    • Analysis by Metabolomics Technology
      • Exhibit 68: Metabolomics (2005-2012) - Japanese Market Analysis (Current & Future) by Metabolomic Technologies for Combined Systems, Hardware Systems and Software Systems in US$ Million (Graphical Representation included)
      • Exhibit 69: Metabolomics (2006, 2009 and 2012) - Percentage Breakdown of Japanese Market Value by Metabolomic Technologies for Combined Systems, Hardware Systems and Software Systems in US$ Million
  • D. Asia-Pacific
    • Market Analysis
      • Exhibit 70: Metabolomics (2005-2012) - Asia-Pacific Market Analysis (Current & Future) in US$ Million (Graphical Representation included)
      • Exhibit 71: List of Major Companies in Asia-Pacific
    • Analysis by Geographic Region
      • Exhibit 72: Metabolomics (2005-2012) - Asia-Pacific Market Analysis (Current & Future) by Geographic Region for China, India, Australia and Rest of Asia-Pacific in US$ Million (Graphical Representation included)
      • Exhibit 73: Metabolomics (2006, 2009 and 2012) - Percentage Breakdown of Asia-Pacific Market Value by Geographic Region for China, India, Australia and Rest of Asia-Pacific (Graphical Representation included)
    • Analysis by Metabolomics Technology
      • Exhibit 74: Metabolomics (2005-2012) - Asia-Pacific Market Analysis (Current & Future) by Metabolomic Technologies for Combined Systems, Hardware Systems and Software Systems in US$ Million (Graphical Representation included)
      • Exhibit 75: Metabolomics (2006, 2009 and 2012) - Percentage Breakdown of Asia-Pacific Market Value by Metabolomic Technologies for Combined Systems, Hardware Systems and Software Systems in US$ Million (Graphical Representation included)
    • Asia-Pacific Market Analysis by Country
  • D1. China
    • Chinese Market Analysis
    • Analysis by Metabolomics Technology
      • Exhibit 76: Metabolomics (2005-2012) - Chinese Market Analysis (Current & Future) by Metabolomic Technologies for Combined Systems, Hardware Systems and Software Systems in US$ Million (Graphical Representation included)
      • Exhibit 77: Metabolomics (2006, 2009 and 2012) - Percentage Breakdown of Chinese Market Value by Metabolomic Technologies for Combined Systems, Hardware Systems and Software Systems in US$ Million
  • D2. India
    • Indian Market Analysis
    • Analysis by Metabolomics Technology
      • Exhibit 78: Metabolomics (2005-2012) - Indian Market Analysis (Current & Future) by Metabolomic Technologies for Combined Systems, Hardware Systems and Software Systems in US$ Million (Graphical Representation included)
      • Exhibit 79: Metabolomics (2006, 2009 and 2012) - Percentage Breakdown of Indian Market Value by Metabolomic Technologies for Combined Systems, Hardware Systems and Software Systems in US$ Million
  • D3. Australia
    • Australian Market Analysis
    • Analysis by Metabolomics Technology
      • Exhibit 80: Metabolomics (2005-2012) - Australian Market Analysis (Current & Future) by Metabolomic Technologies for Combined Systems, Hardware Systems and Software Systems in US$ Million (Graphical Representation included)
      • Exhibit 81: Metabolomics (2006, 2009 and 2012) - Percentage Breakdown of Australian Market Value by Metabolomic Technologies for Combined Systems, Hardware Systems and Software Systems in US$ Million
  • D4. Rest of Asia-Pacific
    • Rest of Asia-Pacific Market Analysis
    • Analysis by Metabolomics Technology
      • Exhibit 82: Metabolomics (2005-2012) - Rest of Asia-Pacific Market Analysis (Current & Future) by Metabolomic Technologies for Combined Systems, Hardware Systems and Software Systems in US$ Million (Graphical Representation included)
      • Exhibit 83: Metabolomics (2006, 2009 and 2012) - Percentage Breakdown of Rest of Asia-Pacific Market Value by Metabolomic Technologies for Combined Systems, Hardware Systems and Software Systems in US$ Million
  • E. Canada
    • Market Analysis
      • Exhibit 84: Metabolomics (2005-2012) - Canadian Market Analysis (Current & Future) in US$ Million (Graphical Representation included)
      • Exhibit 85: List of Major Companies in Canada
    • Analysis by Metabolomics Technology
      • Exhibit 86: Metabolomics (2005-2012) - Canadian Market Analysis (Current & Future) by Metabolomic Technologies for Combined Systems, Hardware Systems and Software Systems in US$ Million (Graphical Representation included)
      • Exhibit 87: Metabolomics (2006, 2009 and 2012) - Percentage Breakdown of Canadian Market Value by Metabolomic Technologies for Combined Systems, Hardware Systems and Software Systems in US$ Million (Graphical Representation included)
  • F. Rest of World
    • Market Analysis
      • Exhibit 88: Metabolomics (2005-2012) - Rest of World Market Analysis (Current & Future) in US$ Million (Graphical Representation included)
      • Exhibit 89: List of Major Companies in Rest of World
    • Analysis by Metabolomics Technology
      • Exhibit 90: Metabolomics (2005-2012) - Rest of World Analysis (Current & Future) by Metabolomic Technologies for Combined Systems, Hardware Systems and Software Systems in US$ Million (Graphical Representation included)
      • Exhibit 91: Metabolomics (2006, 2009 and 2012) - Percentage Breakdown of Rest of World Market Value by Metabolomic Technologies for Combined Systems, Hardware Systems and Software Systems in US$ Million (Graphical Representation included)
• 6. Metabolomics - The Industry Outlook

V. CORPORATE DIRECTORY